골이식편 시장 규모, 점유율, 동향 분석 보고서 : 유형별, 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Bone Allografts Market Growth & Trends:

The global bone allografts market size is anticipated to reach USD 3.53 billion in 2030 and is projected to grow at a CAGR of 9.4% from 2025 to 2030. The rising prevalence of dental problems, ongoing product commercialization, market accessibility & product affordability, rising elderly population, and increasing public awareness regarding preventative care are the major factors driving the demand for dental bone allografts. For instance, about 530 million children experience caries of their primary teeth, according to the World Health Organization (2020), which further estimates that nearly 3.5 billion people are affected by oral disorders. Furthermore, the growing demand for minimally-invasive procedures will also support market growth.

As Minimally Invasive Spine Surgery (MISS) does not require a big incision, it reduces the risk of major injury to the muscles surrounding the spine and allows the surgeon to see only the area of the spine where the problem arises. Due to these approaches, such as using fewer devices, the surgical field (also known as exposure) is smaller, resulting in less pain and a speedier recovery. These factors are expected to drive the overall industry. The industry had a decline in 2020 as a result of the COVID-19 pandemic. All elective surgeries, including spine surgery, were postponed, and the hospitals were transformed into recognized COVID-19 treatment facilities. Such elements consequently hampered the industry expansion.

The expansion of treatment access in many developing countries is likely to increase the demand for healthcare-related products, notably those connected to spinal surgery. The market would expand as a result of the rising demand for these goods, as major developing regions' economies become more prosperous. Furthermore, due to the temporary shutdown of dental clinics and the fact that all healthcare providers were occupied with COVID-19, dental procedure volumes were substantially decreased. Access was limited to only the most basic care. For instance, the American Dental Association (ADA) advised delaying elective dental surgeries until April 6, 2020, and dental offices should only offer emergency dental care. These factors severely impacted the supply chains of dental bone graft substitute producers.

Thus, these data points suggest that during the COVID-19 pandemic, the demand for dental bone graft alternatives decreased. In dentistry, bone allografts are frequently used. A skilled clinician who can handle and position the allografts in the proper position is required for the preparation and processing for safe use and successful transplant material. The materials' antigenicity and danger of disease transfer from donor to the recipient are the main issues. Other bone-related operations, from small flaws to significant bone loss following tumor removal, also use bone allografts. Furthermore, the increasing medical and dental tourism sector, burden of dental illnesses, and technical developments in the field of dentistry are also among the key factors contributing to the industry growth.

Bone Allografts Market Report Highlights:

• An increasing number of sports & trauma injury cases and orthopedic surgeries performed are factors expected to boost the industry growth
• The demineralized bone matrices type segment dominated the industry in 2024 owing to a high number of spinal fusion and dental surgeries performed
• The dental application segment held the largest share of the overall revenue in 2024 and is also expected to register the second-highest CAGR during the forecast period
• To replace missing teeth, bone grafting is done first. Bone grafts are additionally utilized in dentistry as fillers and scaffolds to enhance bone growth & accelerate wound healing, which is expected to propel the segment growth
• The hospitals end-use segment held the largest market share in 2024 due to the availability of technologically sophisticated implants for treating and diagnosing spine problems

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Segment scope
  • 1.1.2. Regional scope
  • 1.1.3. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
• 1.7. Research Assumptions
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type outlook
  • 2.2.2. Application outlook
  • 2.2.3. End Use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Bone Allografts Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
• 3.3. Bone allografts: Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTLE Analysis

Chapter 4. Bone Allografts Market Segment Analysis, By Type, 2018 - 2030 (USD Million)

• 4.1. Definition and Scope
• 4.2. Type Market Share Analysis, 2024 & 2030
• 4.3. Segment Dashboard
• 4.4. Global bone allografts market, by Type, 2018 to 2030
• 4.5. Cortical Bone Allografts
  • 4.5.1. Cortical Bone Allografts market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.6. Cancellous Bone Allografts
  • 4.6.1. Cancellous Bone Allografts market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.7. Corticocancellous Bone Allografts
  • 4.7.1. Corticocancellous Bone Allografts market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.8. Demineralized Bone Matrix
  • 4.8.1. Demineralized Bone Matrix market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Bone Allografts Market Segment Analysis, By Application, 2018 - 2030 (USD Million)

• 5.1. Definition and Scope
• 5.2. Application Market Share Analysis, 2024 & 2030
• 5.3. Segment Dashboard
• 5.4. Global bone allografts market, by Application, 2018 to 2030
• 5.5. Dental
  • 5.5.1. Dental market estimates and forecasts, 2018 to 2030 (USD million)
• 5.6. Spine
  • 5.6.1. Spine market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.7. Reconstruction & Traumatology
  • 5.7.1. Reconstruction & Traumatology market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.8. Others
  • 5.8.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Bone Allografts Market Segment Analysis, By End Use, 2018 - 2030 (USD Million)

• 6.1. Definition and Scope
• 6.2. End Use Market Share Analysis, 2024 & 2030
• 6.3. Segment Dashboard
• 6.4. Global bone allografts Market, by End Use, 2018 to 2030
• 6.5. Hospitals
  • 6.5.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD million)
• 6.6. Others & Trauma Centers
  • 6.6.1. Orthopedic & Trauma Centers market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.7. Others
  • 6.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Bone Allografts Market Segment Analysis, By Region, 2018 - 2030 (USD Million)

• 7.1. Regional Market Share Analysis, 2024 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Regional Market Snapshot
• 7.4. Bone Allografts Market Share by Region, 2024 & 2030:
• 7.5. North America
  • 7.5.1. North America bone allografts market, 2018 - 2030 (USD Million)
  • 7.5.2. U.S.
    • 7.5.2.1. U.S. bone allografts market, 2018 - 2030 (USD Million)
  • 7.5.3. Canada
    • 7.5.3.1. Canada bone allografts market, 2018 - 2030 (USD Million)
  • 7.5.4. Mexico
    • 7.5.4.1. Mexico bone allografts market, 2018 - 2030 (USD Million)
• 7.6. Europe
  • 7.6.1. Europe bone allografts market, 2018 - 2030 (USD Million)
  • 7.6.2. UK
    • 7.6.2.1. UK bone allografts market, 2018 - 2030 (USD Million)
  • 7.6.3. Germany
    • 7.6.3.1. Germany bone allografts market, 2018 - 2030 (USD Million)
  • 7.6.4. France
    • 7.6.4.1. France bone allografts market, 2018 - 2030 (USD Million)
  • 7.6.5. Italy
    • 7.6.5.1. Italy bone allografts market, 2018 - 2030 (USD Million)
  • 7.6.6. Spain
    • 7.6.6.1. Spain bone allografts market, 2018 - 2030 (USD Million)
  • 7.6.7. Norway
    • 7.6.7.1. Norway bone allografts market, 2018 - 2030 (USD Million)
  • 7.6.8. Sweden
    • 7.6.8.1. Sweden bone allografts market, 2018 - 2030 (USD Million)
  • 7.6.9. Denmark
    • 7.6.9.1. Denmark bone allografts market, 2018 - 2030 (USD Million)
• 7.7. Asia Pacific
  • 7.7.1. Japan
    • 7.7.1.1. Japan bone allografts market, 2018 - 2030 (USD Million)
  • 7.7.2. China
    • 7.7.2.1. China bone allografts market, 2018 - 2030 (USD Million)
  • 7.7.3. India
    • 7.7.3.1. India bone allografts market, 2018 - 2030 (USD Million)
  • 7.7.4. Australia
    • 7.7.4.1. Australia bone allografts market, 2018 - 2030 (USD Million)
  • 7.7.5. South Korea
    • 7.7.5.1. South Korea bone allografts market, 2018 - 2030 (USD Million)
  • 7.7.6. Thailand
    • 7.7.6.1. Thailand bone allografts market, 2018 - 2030 (USD Million)
• 7.8. Latin America
  • 7.8.1. Brazil
    • 7.8.1.1. Brazil bone allografts market, 2018 - 2030 (USD Million)
  • 7.8.2. Argentina
    • 7.8.2.1. Argentina bone allografts market, 2018 - 2030 (USD Million)
• 7.9. MEA
  • 7.9.1. South Africa
    • 7.9.1.1. South Africa bone allografts market, 2018 - 2030 (USD Million)
  • 7.9.2. Saudi Arabia
    • 7.9.2.1. Saudi Arabia bone allografts market, 2018 - 2030 (USD Million)
  • 7.9.3. UAE
    • 7.9.3.1. UAE bone allografts market, 2018 - 2030 (USD Million)
  • 7.9.4. Kuwait
    • 7.9.4.1. Kuwait bone allografts market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company Categorization
• 8.3. Company Profiles
  • 8.3.1. Stryker
    • 8.3.1.1. Company overview
    • 8.3.1.2. Financial performance
    • 8.3.1.3. Product benchmarking
    • 8.3.1.4. Strategic initiatives
  • 8.3.2. Zimmer Biomet
    • 8.3.2.1. Company overview
    • 8.3.2.2. Financial performance
    • 8.3.2.3. Product benchmarking
    • 8.3.2.4. Strategic initiatives
  • 8.3.3. Smith+Nephew
    • 8.3.3.1. Company overview
    • 8.3.3.2. Financial performance
    • 8.3.3.3. Product benchmarking
    • 8.3.3.4. Strategic initiatives
  • 8.3.4. Medtronic
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. Lynch Biologics, LLC
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. Biomatlante
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. Johnson & Johnson Services, Inc.
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. Royal Biologics
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. Baxter
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. Xtant Medical
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives